Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating hepatitis and liver cirrhosis

A technology for compositions and medicines, which can be used in medicine combinations, digestive systems, pharmaceutical formulations, etc., and can solve the problems of long time and insignificant curative effect.

Inactive Publication Date: 2014-04-23
广州鸿源高新科技有限公司
View PDF6 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the prior art has inconspicuous curative effect, long time and other deficiencies. The treatment of hepatitis and liver cirrhosis urgently needs a Chinese medicine composition with good effect, quick effect and little side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating hepatitis and liver cirrhosis
  • Pharmaceutical composition for treating hepatitis and liver cirrhosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Washing Fruit 180g, Bupleurum 210g, Salvia 180g, Sanleng 210g, Curcuma 180g, Jiazhu 210g, Yinchen 180g, Soapthorn 180g, Ginseng 150g, Aconite 180g, Angelica 150g, Tortoise Shell 180g, Turtle Shell 150g, Dandelion 180g, Qingdai 150g, Panax notoginseng 180g, Wang Buliuxing 150g.

[0052] Weigh the above raw materials according to the ratio, add water to decoct twice, add 7 times the amount of water for the first time, decoct for 1.5 hours, add 8 times the amount of water for the second time, decoct for 1.5 hours, combine the decoction, filter, and filtrate Concentrate the extract to a relative density of 1.30 (measured at 70°C), add a conventional amount of magnesium stearate auxiliary material, and make tablets according to a conventional process, with a specification of 0.5g / tablet.

Embodiment 2

[0054] Washing Fruit 210g, Bupleurum 180g, Salvia 210g, Sanleng 180g, Curcuma 210g, Jiazhu 180g, Yin Chen 210g, Soapthorn 150g, Ginseng 180g, Aconite 150g, Angelica 180g, Tortoise Shell 150g, Turtle Shell 180g, Dandelion 150g, Qingdai 180g, Panax notoginseng 150g, Wang Buliuxing 180g.

[0055] Weigh the above raw materials according to the ratio, add water to decoct twice, add 7 times the amount of water for the first time, decoct for 1.5 hours, add 8 times the amount of water for the second time, decoct for 1.5 hours, combine the decoction, filter, and filtrate Concentrate the extract to a relative density of 1.30 (measured at 70°C), add an appropriate amount of sucrose powder, and make granules according to the conventional process.

Embodiment 3

[0057] Washing Fruit 180g, Bupleurum 180g, Salvia 180g, Sanleng 180g, Curcuma 180g, Jiazhu 180g, Yin Chen 180g, Soapthorn 180g, Ginseng 180g, Aconite 180g, Angelica 180g, Tortoise Shell 180g, Turtle Shell 180g, Dandelion 180g, Qingdai 180g, Panax notoginseng 180g, Wang Buliuxing 180g.

[0058] Weigh the above raw materials, add water to decoct twice, add 8 times the amount of water for the first time, decoct for 2 hours, add 6 times the amount of water for the second time, decoct for 1.5 hours, combine the decoctions, filter to obtain a decoction.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating hepatitis and liver cirrhosis. The pharmaceutical composition is prepared from 18-21 parts of sapindus mukorossi gaertn, 18-21 parts of radix bupleuri, 18-21 parts of salvia miltiorrhiza, 18-21 parts of rhizoma sparganii, 18-21 parts of curcuma zedoary, 18-21 parts of pangolin scales, 18-21 parts of herba artemisiae scopariae, 15-18 parts of spina gleditsiae, 15-18 parts of ginseng, 15-18 parts of aconitum carmichaili, 15-18 parts of angelica sinensis, 15-18 parts of tortoise shell, 15-18 parts of turtle shell, 15-18 parts of dandelion, 15-18 parts of indigo naturalis, 15-18 parts of pseudo-ginseng and 15-18 parts of cowherb seed by weight as active ingredients. The defects of the existing medicaments for treating hepatitis and liver cirrhosis are overcome, and a pharmaceutical composition which is good in effects of treating hepatitis and liver cirrhosis is provided.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating hepatitis and liver cirrhosis. Background technique [0002] Hepatitis, namely viral hepatitis (viral hepatitis), is an infectious disease mainly caused by liver lesions caused by a variety of hepatitis viruses. According to etiological diagnosis, there are at least 5 types of hepatitis viruses, namely hepatitis A, B, C, D, and E, which cause viral hepatitis A, B, C, D, and E respectively, namely hepatitis A. , hepatitis B (hepatitis B), hepatitis C (hepatitis C), hepatitis D (hepatitis D) and hepatitis E (hepatitis E). Among them, viral hepatitis A and E mainly manifest as acute hepatitis; hepatitis B and C can manifest as acute hepatitis or chronic hepatitis, and may develop into liver cirrhosis and hepatocellular carcinoma. Clinically, the main manifestations are loss of appetite, nausea, upper abdominal discomfo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P1/16A61K35/56A61K35/36A61K35/586
Inventor 李绍华
Owner 广州鸿源高新科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com